HB Wealth Management »

Abcellera Biologics shares owned by HB Wealth Management

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by HB Wealth Management from 13F filings

Historical chart of HB Wealth Management investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by HB Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by HB Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $65k 19k 3.42
2025-09-30 $146k 29k 5.03

More positions owned by HB Wealth Management

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
American Centy Etf Tr Us Eqt Etf (AVUS)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Spdr Series Trust State Street Spd (SPYG)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr S&p 500 Grwt Etf (IVW)
Microsoft Corporation (MSFT)
Home Depot (HD)
NVIDIA Corporation (NVDA)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)

View all positions for HB Wealth Management

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Ubs Global Asset Management Americas
Two Sigma Investments
Two Sigma Advisers
Goldman Sachs Group
Arrowpoint Asset Management
BlackRock
Millennium Management
Renaissance Technologies
Susquehanna International
UBS Group
Guardian Partners
Driehaus Capital Management
Jane Street

View all funds holding Abcellera Biologics